These can include injection-site redness, flushing, increased hunger, water retention, or a mild headache
After providing written informed consent, research participants completed a screening assessment at CAMH
Basel: Springer
4.21, 14.02, 42.13, 84.27, 140.45 nmol/kg over 15 minutes) with peak GH release occurring ~0.67 hours post-infusion and a terminal half-life 2 hours
The OD value may be higher when directly reading at 450nm
225,226,227,228 Backbone modification The modification strategies used in first-generation NADs have focused on modification of the phosphate backbone, mainly using other types of groups to replace the non-bridging oxygen atoms in the phosphate backbone, such as phosphorothioate (PS), methyl phosphate, and boranophosphate